FFLDX
Price
$27.90
Change
-$0.03 (-0.11%)
Updated
Jul 28 closing price
Net Assets
24.36B
TRRNX
Price
$25.08
Change
-$0.00 (-0.00%)
Updated
Jul 28 closing price
Net Assets
12.05B
Interact to see
Advertisement

FFLDX vs TRRNX

FFLDX vs TRRNX Comparison Chart in %
View a ticker or compare two or three
VS
FFLDX vs. TRRNX commentary
Jul 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFLDX is a Hold and TRRNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FFLDX has more cash in the bank: 24.4B vs. TRRNX (12B). FFLDX pays higher dividends than TRRNX: FFLDX (1.71) vs TRRNX (1.14). FFLDX was incepted earlier than TRRNX: FFLDX (11 years) vs TRRNX (20 years). TRRNX (0.63) is less costly to investors than FFLDX (0.08). FFLDX is a more actively managed with annual turnover of: 13.00 vs. TRRNX (11.00). TRRNX has a lower initial minimum investment than FFLDX: TRRNX (2500) vs FFLDX (5000000). FFLDX annual gain was more profitable for investors over the last year : 18.98 vs. TRRNX (15.78). FFLDX return over 5 years is better than : 53.81 vs. TRRNX (27.46).
FFLDXTRRNXFFLDX / TRRNX
Total Expense Ratio0.080.6313%
Annual Report Gross Expense Ratio0.080.6313%
Fund Existence11 years20 years-
Gain YTD9.75310.29095%
Front LoadN/AN/A-
Min. Initial Investment50000002500200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets24.4B12B203%
Annual Yield % from dividends1.711.14149%
Returns for 1 year18.9815.78120%
Returns for 3 years57.4046.73123%
Returns for 5 years53.8127.46196%
Returns for 10 years144.78107.29135%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTHIX40.700.54
+1.34%
Invesco Health Care Invstor
AAGOX115.05N/A
N/A
Alger Large Cap Growth I-2
GSPKX19.88N/A
N/A
Goldman Sachs US Eq Div and Prem Instl
RNNEX76.91-0.98
-1.26%
American Funds New Economy R-2E
MCYAX15.47-0.62
-3.85%
NYLI Candriam Emerging Markets Eq Cl A